CompletedNot Applicable

Adding 1% Metformin Gel to Bone Graft in Association With Immediate Dental Implants

Egypt20 participantsStarted 2022-11-01

Plain-language summary

This study aimed to investigate whether combining xenografts with Metformin Gel gel enhances bone regeneration and improves implant outcomes.

Who can participate

Age range18 Years – 40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age from 18 to 40 years. * Both sexes. * Adult individual with non-restorable tooth in esthetic and premolars area and seeking for immediate implant placement. * Systemically healthy patients were selected for implant surgery according to the criteria of Cornell medical index and its modifications. * The recipient site of the implant should be free from any pathological conditions. * Sufficient vertical bone height to safely place at least 12 mm long dental implant. Exclusion Criteria: * Smokers. * Pregnant or lactating female patients. * Patients with parafunctional habits such as bruxism and clenching. * Presence of acute infection around the failing tooth. * Perforation and/or loss of the labial bony plate following tooth removal and/or implant osteotomy. * Inability to attain primary implant stability following immediate implant placement.

What they're measuring

Assessment of Implant primary stability

Timeframe: 12 months after implant placement

Trial details

NCT IDNCT07469254

SponsorAl-Azhar University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-09-01

View on ClinicalTrials.gov More Metformin Gel trials